The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi (Q45779956)
Jump to navigation
Jump to search
scientific article published in May 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi |
scientific article published in May 1993 |
Statements
1 reference
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi (English)
1 reference
M J O'Sullivan
1 reference
P J Boyer
1 reference
G B Scott
1 reference
W P Parks
1 reference
S Weller
1 reference
M R Blum
1 reference
J Balsley
1 reference
Y J Bryson
1 reference
1 May 1993
1 reference
168
1 reference
5
1 reference
1510-1516
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference